Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuyuki Ono

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Scientific Reports|January 26, 2019
Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosisShoichi Fukui, Ayako Kuwahara-Takaki, Nobuyuki Ono, et al.
Rheumatology (Oxford, England)|June 8, 2023
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patientsYusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2015
Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012)Noriaki Kawano, Shuro Yoshida, Takuro Kuriyama, et al.
Frontiers in Immunology|March 27, 2023
Association of <i>HLA</i>-<i>class II</i> alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese populationAya Kawasaki, Ken-Ei Sada, Premita Ari Kusumawati, et al.
International Journal of Rheumatic Diseases|December 22, 2023
Recent advances in the treatment strategy for AAV improved outcomes with intensive GC taperingNobuyuki Ono, Tatsuya Kai, Yukiko Takeyama, et al.
Modern Rheumatology|July 4, 2020
Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in JapanYukiko Takeyama, Nobuyuki Ono, Yuri Shirahama, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2014
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseasesNoriaki Kawano, Akira Tasaki, Takuro Kuriyama, et al.
Modern Rheumatology|May 9, 2025
Characterization of patients with rheumatoid arthritis not using biologic/targeted synthetic disease-modifying drugs despite insufficient disease control: Another difficult-to-treat RAHisakata Yamada, Ryosuke Tsurui, Masakazu Kondo, et al.
Clinical and Experimental Rheumatology|January 14, 2025
Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registryYukio Akasaki, Hisakata Yamada, Masakazu Kondo, et al.
RMD Open|July 10, 2026
Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populationsAya Kawasaki, Ikue Ito-Naito, Mina Sato, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Scientific Reports|January 26, 2019
Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosisShoichi Fukui, Ayako Kuwahara-Takaki, Nobuyuki Ono, et al.
Rheumatology (Oxford, England)|June 8, 2023
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patientsYusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2015
Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012)Noriaki Kawano, Shuro Yoshida, Takuro Kuriyama, et al.
Frontiers in Immunology|March 27, 2023
Association of <i>HLA</i>-<i>class II</i> alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese populationAya Kawasaki, Ken-Ei Sada, Premita Ari Kusumawati, et al.
International Journal of Rheumatic Diseases|December 22, 2023
Recent advances in the treatment strategy for AAV improved outcomes with intensive GC taperingNobuyuki Ono, Tatsuya Kai, Yukiko Takeyama, et al.
Modern Rheumatology|July 4, 2020
Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in JapanYukiko Takeyama, Nobuyuki Ono, Yuri Shirahama, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2014
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseasesNoriaki Kawano, Akira Tasaki, Takuro Kuriyama, et al.
Modern Rheumatology|May 9, 2025
Characterization of patients with rheumatoid arthritis not using biologic/targeted synthetic disease-modifying drugs despite insufficient disease control: Another difficult-to-treat RAHisakata Yamada, Ryosuke Tsurui, Masakazu Kondo, et al.
Clinical and Experimental Rheumatology|January 14, 2025
Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registryYukio Akasaki, Hisakata Yamada, Masakazu Kondo, et al.
RMD Open|July 10, 2026
Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populationsAya Kawasaki, Ikue Ito-Naito, Mina Sato, et al.
Pageof 7